$EA

cmtek81.. ciao i miei sono manuali con gestione del TP da un gestionale EA.

Only Comcast is more hated than EA

i can hear this in my head > @dros said: EA SPORTS ITS IN THE GAME

EA SPORTS ITS IN THE GAME

this is huge > @truublue said: FIFA is ending its longstanding exclusive partnership with EA Sports, a statement reads:“FIFA is bullish and excited about the future in gaming and esports for football, and it is clear that this needs to be a space that is occupied by more than one party controlling all rights.” https://t.co/VoYBBn7flY

FIFA is ending its longstanding exclusive partnership with EA Sports, a statement reads:“FIFA is bullish and excited about the future in gaming and esports for football, and it is clear that this needs to be a space that is occupied by more than one party controlling all rights.” https://t.co/VoYBBn7flY

RECAP 10/13 Chatter: $DKNG + NHL $M - No E-Commerce spin $BA - FAA Consider Engine redesign $CTXS + $AVGO (Gordon Haskett) $EA - FIFA Talks stall $TWTR + Conversation Ads $ZNGA+ $DIS Game collab? $UPS - $AMZN Cargo jet shopping $ORPH + Patent $CFRX + Patent $LULU + Footwear

Unusually heavy option volume on today's open include $LUV, $CTXS, $EA, $PSX, and $HES.

no no ma tranquillo, io ti credo perché sennò non credo che avresti scritto una baggianata 😉. Era solo per capire perché io, per esempio, riesco a farne al max 6 di operazioni ed opera senza EA..solo invidia e curiosità!! tutto qui ;)

Tutto trading Manuale...😉 tranne impostazione take profit e stop dove uso un mio EA...quello che hai visto è replicabile anche in reale , non cambia nulla...

@leemiller200 been holding EA for short for 3 days now

Unusually active option classes on open October 4th $ADVM $TGP $VTNR $PROG $EA $MRK $BTU $XLE $OXY

anybody catch chunk of $EA move?

$EA looks okay

2000 $EA OCT2021 $145 Cs trade 1.15

2000 $EA OCT2021 $145 Cs trade 1.15

2000 $EA Oct21 145 Calls trade $1.15 (Cboe Theo=1.07) ASKSIDE PHLX IV=29.6% -0.5 FLOOR Vol=7095, OI=5829,

This list is ALL bullish this week. $BABA, $CCJ, $CIEN, $DE, $DHI, $FCX, $LLY, $LMND, $SPOT, $STZ, $WPM, $XPEV, $YUM, THESE HAVE the Wu options column not a Wu-Tang pattern the meet options oi is greater than volume $BILI, $DKNG, $EA, $FSLR, $JD, $NTES, $PDD, $WB, $ZM

Thursday, September 16, 2021 U.S. futures are pointing to a lower open, pulling back ahead of weekly jobless claims and retail sales data (economists are looking for a 0.8% drop in retail sales for August, compared with a 1.1% fall the month) while Asian markets fell for a 4th straight day following China’s broadening crackdown on corporate profitability. In Asian markets, The Nikkei Index fell -188 points to 30,323, the Shanghai Index dropped -49 points (1.34%) to 3,607 and the Hang Seng Index tumbled -365 points to 24,667. In Europe, the German DAX is up about 75 points to 15,690, while the FTSE 100 is higher by 30-points to 7,050. Oil prices are flat after marching higher yesterday after Energy Department data showed a bigger-than-expected 6.4 million decline in domestic stockpiles. The stock market erased most of this week’s losses, on Wednesday, eyeing a low-volume trading day today for Yom Kippur as some investors and traders leaving early. The S&P 500 rose +0.9% and Dow a +0.7% climb and the Nasdaq rose +0.8%, snapping its 5-day losing streak. Ten out of eleven S&P sectors were higher led by Energy. Market Closing Prices Yesterday · The S&P 500 Index gained 37.65 points, or 0.85%, to 4,480.70 · The Dow Jones Industrial Average rose 236.82 points, or 0.68%, to 34,814.39 · The Nasdaq Composite surged 123.77 points, or 0.82%, to 15,161.53 · The Russell 2000 Index advanced 24.46 points, or 1.11% to 2,234.45 Events Calendar for Today · 8:30 AM ET Weekly Jobless Claims…est. 330K · 8:30 AM EST Continuing Claims…est. 2.785M · 8:30 AM ET Philly Fed Index for September…est. 18.8 · 8:30 AM ET Retail Sales MoM for Aug…est. (-0.8%) · 8:30 AM ET Retail Sales Ex: Autos MoM for Aug…est. (-0.1%) · 10:00 AM ET Business Inventories MoM for July…est. +0.5% · 10:30 AM ET Weekly EIA Natural Gas Inventory Data · 4:00 PM ET Net Long-term TIC Flows for July Earnings Calendar: · Earnings Before the Open: IPHI, LMNX · Earnings After the Close: HRB Other Key Events: · Citigroup Small/Mid-Cap & Growth Conference 2021 (virtual), 9/16-9/17 · European Society for Medical Oncology (ESMO) 2021 Virtual Congress, 9/16-9/21 World News · The United States, Britain and Australia announced a new security partnership for the Indo-Pacific in a move hailed by regional allies but denounced by China as intensifying an arms race in the region. Under the partnership, announced by President Joe Biden, British Prime Minister Boris Johnson and Australian Prime Minister Scott Morrison, the United States and Britain will provide Australia with the technology and capability to deploy nuclear-powered submarines. · US House Ways and Means Committee votes to advance plan to raise taxes on wealthy Americans and corporations as part of Democrats’ reconciliation spending bill Sector News Breakdown Consumer · Beyond Meat (BYND) downgraded to Underweight from Neutral with a price target of $95, down from $120 at Piper saying the company’s current all-channel retail momentum will lag consensus expectations and foodservice consensus estimates may be high · AMC Entertainment (AMC) CEO Aron said yesterday that AMC Theatres will accept Bitcoin for online ticket and concession payments, and similarly accept other cryptocurrencies like Ethereum, Litecoin and Bitcoin Cash. · Callaway Golf ($ELY) 4M share Secondary priced at $29.25 · Figs ($FIGS) 8.92M share Secondary priced at $40.25 · Molson Coors Beverage Co. ($TAP) said it plans to expand distribution of its Topo Chico Hard Seltzer nationwide, starting January 2022 · China’s leading ride-hailing app, Didi ($DIDI), has seen its daily users fall by 30% since its initial public offering in New York in June triggered a fierce backlash by Beijing, the Financial Times reported. https://on.ft.com/2XmIqy8 · Laureate Education, Inc. ($LAUR) said its Board approved a plan of partial liquidation (the “Plan”) in connection with the previously disclosed sale of Walden e-Learning LLC Energy, Industrials and Materials · Timken ($TKR) said it expects lower sales and earnings in second half of 2021; said underlying customer demand and end-market momentum remain strong across most sectors and expects a robust industrial market environment for remainder of 2021 and throughout 2022 · Ion Geophysical ($IO) announced that its board of directors has initiated a process to evaluate a range of strategic alternatives in an effort to strengthen its financial position and maximize stakeholder value · Pioneer Natural Resources ($PXD) increased its 2030 goals to a 50% reduction in GHG intensity and a 75% reduction in methane intensity from 2019 baseline · Sibanye Stillwater ($SBSW) agrees to acquire half of Ioneer Ltd.’s Nevada lithium project for $490M – Reuters · The Association of American Railroads reports total weekly US rail traffic down 1.3% Y/Y to 468,610 carloads and intermodal units for the week ending September 11, 2021; Carloads up 4.5% to 223,710; intermodal volume down 6% to 244,900 containers · SpaceX successfully launched four civilians into space Wednesday evening in the first spaceflight staffed wholly by commercial astronauts, which is not a government-backed crew to orbit Earth. The aerospace company run by Elon Musk launched the crew of Inspiration4 from NASA’s Kennedy Space Center shortly after 8 p.m. ET on Wednesday. The mission will take the four astronauts 360 miles from Earth for at least three days before they splash down in one of several spots off the Florida coast. Financials · Enact Holdings ($ACT) 13.31M share IPO priced at $19.00 · Veritex ($VBTX) boosts share buyback to $250M from $175M Healthcare · Aerie Pharmaceuticals ($AERI) shares fall -19%; a Phase 2b study of the company’s experimental treatment for dry eye disease failed to meet the main goal of the trial · Exelixis ($EXEL) announces results from Phase 3 CheckMate -9ER trial demonstrating efficacy benefits regardless of prior nephrectomy status with Cabometyx (cabozantinib) in combination with Bristol Myers Squibb’s (BMY) Opdivo (nivolumab) vs. sunitinib for patients with previously untreated advanced renal cell carcinoma (RCC). · Moderna ($MRNA) said a study of breakthrough COVID-19 cases among vaccinated individuals supports the need for a booster shot. Moderna identified 88 breakthrough COVID cases among 11,431 people vaccinated between December 2020 and March 2021, but 162 cases in the group who got their shots between July and October of last year. · Travere Therapeutics ($TVTX) reported a joint collaboration and licensing agreement with Vifor Pharma for the commercialization of Sparsentan in Europe, Australia and New Zealand · BioXcel Therapeutics ($BTAI) presents results from ongoing phase 2 trial of BXCL701 in combination with KEYTRUDA® in aggressive forms of prostate cancer at ESMO · The FDA has decided not to take a stand on the efficacy of a booster shot from Pfizer ($PFE), as the agency says it doesn’t have enough data to make a decision, and that it’s only seen an observational study in Israel. · Invitae Corp ($NVTA) files for stock shelf of up to 6.3 mln common shares by the selling stockholders · Takeda’s ($TAK) EXKIVITY™ (mobocertinib) approved by U.S. FDA as the first oral therapy specifically designed for patients with EGFR Exon20 Insertion+ NSCLC Technology, Media & Telecom · Electronic Arts ($EA) announces Battlefield 2042 is now set to launch worldwide on November 19, 2021 (shares of EA fell yesterday on talk it might have been delayed into 2022, but launch also a month later than originally expected); reiterating net bookings guidance for fiscal year 2022 provided on august 4, 2021, despite this change in launch date for Battlefield 2042 · Cisco ($CSCO) upgraded to Outperform from Neutral at Credit Suisse at Credit Suisse · ForgeRock ($FORG) 11M share IPO priced at $25.00 · Texas Instruments ($TXN) raises quarterly dividend 13% to $1.15 from $1.02 per share · Adobe ($ADBE) announced the upcoming availability of Payment Services for Adobe Commerce, “the industry’s leading end-to-end commerce application for B2B, D2C and hybrid use cases · InterDigital ($IDCC) sees Q3 revenue $119M-$121M vs. est. $111.64M, driven by both an expected $15M of recurring revenue and $30M of non-recurring revenue from a fixed price license agreement signed during Q

question mark is vs positive or negative, it's ambiguous > @AJAJ said: yes on CSCO .. they are having virtual investor day .. no question mark in that :) $EA - Battlefield Delay $NLSN - Rival Co? $RSI + Fanatics $CSCO ? Investor day Guidance $APRN ? Capital Raise $TGNA + Chatter

yes on CSCO .. they are having virtual investor day .. no question mark in that :) > @HeyShoe said: RECAP 9/15 Chatter: $EA - Battlefield Delay $NLSN - Rival Co? $RSI + Fanatics $CSCO ? Investor day Guidance $APRN ? Capital Raise $TGNA + Chatter

RECAP 9/15 Chatter: $EA - Battlefield Delay $NLSN - Rival Co? $RSI + Fanatics $CSCO ? Investor day Guidance $APRN ? Capital Raise $TGNA + Chatter

metti ordine pending con nel commento la password investitore che ti da MYFX poi aggiorna EA

metti ordine pending con nel commento la password investitore che ti da MYFX poi aggiorna EA

si dopo aver provare anche con EA ! pero' rimane privato per adesso non so se devo aspettare o non ho fatto tutto correttamente

apri conto MT4 installi EA metti User e pws di MYFX sull'EA poi fai la verifica inserendo un pending con commento la password che ti da MYFX e lo verica da solo

ho il conto demo aperto sulla ctrader > @Massimo74 said: stai usando EA ??

stai usando EA ??

viene spesso (e maggiormente utilizzata) quando si costruiscono gli EA, ma se la sai utilizzare porta enormi profitti anche nel trading discrezionario

Qué les parece $EA? Me gusta el MACD

@EmporosAdmin i am fully prepared, i can get our WM1 account set up within an hour, and email the EA right after

i am going to explore you EA website, got some free time

DAmmit I took Profit on $ATVI at 1.45 ea from .55

@Puffin do you have your EA robot in mql5 or any online holder

$ETSY My Level: LONG at $168 - $164 This could change in the morning. Their conf call was at 5pm this evening. Looking at the Volume Profile POC is sitting right at 168. The quarterly pivot is sitting on 164. My Level: SHORT at 183.88 - 185.08 On the flip side if we can get an early push into the 50d and 200d area I'll be looking for a fade. $FSLY My Level: SHORT at $40 and $41 Why: I'm looking for a fade on this on a pop. This has a $2 - $3 range on this. When you look at their earnings, the top line they missed by a hair and they are talking about cutting their fiscal year 21. No one likes when they start cutting guidance. This is a name that is already breaking down and could remain heavy. Sometimes these are the easiest trades. Could give us the opportunity for a slow fade. $LMND My Level: LONG at $78.50 Why: Prior support. Best spot is 74.30 on the quarterly pivot. It has $5 range. Decent. Numbers were in line. Slight bottom line miss. Guidance seemed ok. I'm looking at bounce play. They came in on a loss of $0.90 instead of $0.88. Should be a good bounce play on tomorrow's open. $UBER My Level: LONG at $37.60 Why:Monthly pivot. Usually only has $1.50 range. My Level: SHORT at $41.60-41.80 Why:Looking for a fade into G2C (gap to close). Any push into that would be a fade. Purely technical play. $DXC My Level: SHORT at $41.95 Why: Only $1.50 range. I like to include interesting names that aren't on anyone else's scan can, knock-on-wood, end up being easier trades. The numbers were unimpressive. The monthly pivot and previous close are right here. $EA My Level: LONG at $140.30 Why: Numbers and guidance were ok. This level is on the monthly pivot, prior support, above G2C. Looking for G2C (gap to close) type play. $PTON My Level: LONG at $115.80 Why: 50d support. $AKAM My Levels: LONG at $110.30 and 107.50 Why: You can't ignore that 107.50 area. 200d, monthly pivot. 110.30 is previous month pivot and previous low. When their earnings reported everything seemed in line. They even raised their fiscal 2021 earnings

Healthcare Moderna ($MRNA) Q2 EPS $6.46 vs. est. $6.04; Q2 revs $4.4B vs. est. $4.28B; expects dose capacity for its covid-19 vaccine in fy 2021 to be between 800 mln and 1 bln doses; advance purchase agreements signed for expected product sales of $20 bln in 2021, including sales already recorded in 6 months ended June 30; signed agreements for $12 bln worth of sales for covid-19 vaccine in 2022, option for about $8 bln more; continue to expect $450 mln -$550 mln of capital investments for 2021 Cigna ($CI) Q2 adj EPS $5.24 vs. est. $4.96; Q2 revs $43.13B vs. est. $41.31B; pharmacy customer base at Q2 grew to 101.9M, an organic increase of 3.1M year to date; total medical customer base at Q2 was 17M, an increase of 279,000 customers YTD; Q2 profit overall fell -16% hurt by higher medical costs; backs year EPS but ups its rev guidance to at least $170B from $166B Nevro ($NVRO) slides after withdrawing FY forecast on COVID-19 concerns and guided Q3 sales between $90M-$93M which is below analyst estimates of $114.7M Regeneron Pharma ($REGN) phase 3 Trial of Libtayo combined with chemotherapy stopped early due to significant improvement in overall survival in patients with first-line advanced non-small cell lung cancer Abiomed ($ABMD) Q1 adj EPS $1.10 vs. est. $1.05; Q1 revs $252.6M vs. est. $240.91M; raises FY22 revenue view to $1.03B-$1.05B from prior $990M-$1.03B (22%-24% growth); expects its fiscal year 2022 non-GAAP operating margin to be in the range of 24% to 26% Amedisys ($AMED) announces new $100M share repurchase program; Q2 adj EPS $1.69 vs. est. $1.67; Q2 revs $564.2M vs. est. $566.19M; guides 2021 adj EPS $6.37-$6.49 vs. est. $6.96; sees 2021 adj net service revenue $2.23B-$2.245B. Evolent Health ($EVH) 2Q EPS ($0.11) vs est. ($0.04) on revs $222.1Mm vs est. $216.9Mm; guides 3Q revs $215-230Mm vs est. $217.7Mm, sees FY revs $870-900Mm vs est. $870.8Mm; announces agreement to acquire Vital Decisions outstanding equity interests for aggregate price up to $130Mm, says transaction is accretive to EBITDA/share before synergies McKesson ($MCK) Q1 adj EPS $5.56 vs. est. $4.15; Q1 revs $62.7B vs. est. $59.99B; raises FY22 adj EPS view to $19.80-$20.40 from prior view $18.85-$19.45 (est. $19.23) 1life Healthcare, Inc. ($ONEM) Q2 EPS loss (-$0.30) vs. est. loss (-$0.20); Q2 revs $120.4M vs. est. $115.7M; sees Q3 revs $113M-$120M vs. est. $118M; sees year revs $475M-$485M vs. est. $482.3M; Membership count as of quarter-end was 621,000 compared to 475,000, a 31% increase; Adjusted EBITDA was positive $6.9 million, or 6% of net revenue Sarepta Therapeutics ($SRPT) Q2 non-GAAP EPS loss (-$1.52) vs. est. loss (-$1.26); net product sales for q2 reached $141.8 mln, a 27% increase over same quarter of prior year; raises full-year product revenue guidance by nearly $30 mln to between $565 mln to $575 mln Tandem Diabetes ($TNDM) 2Q revs $172.1Mm vs est. $143.4Mm; guides FY sales $670-685Mm vs est. $637Mm; guides FY adj EBITDA mgn about 15% vs est. 13.5% Industrials & Materials Albemarle ($ALB) Q2 adj EPS $0.89 vs. est. $0.83; Q2 revs $773.9M vs. est. $788.6M; qtrly lithium net sales of $320.3 mln increased $36.6 mln yoy primarily driven by higher volumes; full-year 2021 net sales guidance improved vs previous guidance primarily due to increased lithium sales, improving catalysts trends – sees year sales $3.3B-$3.4B vs. est. $3.24B Hillenbrand ($HI) 3Q adj EPS $0.85 vs est. $0.76 on revs $695Mm; guides 4Q adj EPS $0.82-0.92 vs est. $0.85, sees 4Q revs $713-738Mm vs est. $709.1Mm Maxar Technologies ($MAXR) 2Q EPS $0.60 vs est. $0.14 on revs $473Mm vs est. $441.5Mm Summit Materials ($SUM) 2Q EPS $0.48 vs est. $0.52 on revs $618.5Mm vs est. $647.1Mm; no change to FY guide Valvoline ($VVV) Q3 adj EPS $0.55 vs. est. $0.45; Q3 revs $792M vs. est. $745.32M; Q3 retail Services system-wide same-store sales grew 40.5%; Q3 same-store sales rose 27%; sees FY sales growth 25%-26% and FCF $250M-$270M Media & Telecom Fox Corp. ($FOXA) Q4 adj EPS $0.65 vs. est. $0.57; Q4 revs $2.89B vs. est. $2.75B; raises semi-annual dividend to 24c; cable network programming reported quarterly segment revenues of $1.40B, an increase of $128M; affiliate revenues increased 10% with 16% growth at the television segment and 6% growth at the cable network programming segment in q4 Roku Inc. ($ROKU) Q2 EPS 52c vs est. 13c on revs $645M vs est. $618.4M, average rev per user $36.46 (+46% YoY), active accounts 55.1M vs est. 55.8M; at midpoint of Q3 guidance, sees revs $675M-$685M vs est. $645M, gross profit $315M-$325M, adj EBITDA $60M-$70M, net income (-$3M)-$7M, anticipates sequential increases in operating expenses in 2H from investments in headcount, product development, and sales & marketing Technology Amdocs Ltd. ($DOX) 3Q adj EPS $1.35 vs est. $1.18 on revs $1.066B vs est. $1.06B; guides 4Q adj EPS $1.13-1.19 vs est. $1.28, sees 4Q revs $1.065-1.105B vs est. $1.087B Booking Holdings ($BKNG) 2Q adj EPS ($2.55) vs est. ($2.04) on revs $2.2B vs est. $1.9B, encouraged by sequential improvement in booking trends with 2Q room nights +59% vs 1Q; said in in q2, we saw the first sequential increase in the number of properties on booking.com and lowest number of properties coming off of our platform since the onset of the covid-19 pandemic DXC Technology ($DXC) Q1 adj EPS $0.84 vs. est. $0.74; Q1 revs $4.14B vs. est. $4.11B; Q2 guidance falls short of views but backs year EPS view $3.45-$3.65 vs. est. $3.56 and backs FY22 revenue view $16.6B-$16.8B (est. $16.74B); Bookings of $4.6 billion and book-to-bill ratio of 1.12x in Q1 FY22 Electronic Arts ($EA) Q1 EPS $0.71 vs. est. $0.62; Q1 net bookings $1.336B vs. est. $1.28B; sees Q2 EPS roughly $0.36 vs. est. $1.07; sees Q2 net bookings $1.725B vs. est. $1.62B; raises FY22 EPS view to $1.58 from $1.34 and ups FY21 bookings view to $7.4B from $7.3B Fastly Inc. ($FSLY) shares fall -18%; Q2 adj EPS ($$0.15) vs est. ($0.17) on revs $85.03M vs est. $85.7M, sees Q3 EPS loss (21c)-(18c) vs est. (18c) on revs $82M-$85M vs est. $97.9M, and forecasts FY EPS (65c)-(57c) vs est. (43c) on revs $340M-$350M vs est. $382.5M GoDaddy ($GDDY) Q2 EPS $0.27 vs. est. $0.32; Q2 revs $931.3M vs. est. $919.7M; total bookings of $1.055B, up 12.7% year over year, or 10.6% on a constant currency basis; Domains revenue of $436.7 million, up 18.2% yoy; Hosting and presence revenue of $318.5 million, up 9.0% yoy; Business applications revenue of $176.1 million, up 21.8% yoy; sees year revs $3.75B, in-line HubSpot ($HUBS) 2Q adj EPS $0.43 vs est. $0.32 on revs $310.8Mm vs est. $296Mm; guides 3Q adj EPS $0.42-0.44 vs est. $0.39, sees 3Q revs $325-327Mm vs est. $318.7Mm; guides FY revs $1.268-1.272B vs est. $1.244B MercadoLibre ($MELI) Q2 EPS $1.37 vs est. $0.19 on revs $1.7B vs est. $1.48B with commerce revs +96.4% YoY and fintech revs +88.9%; unique active users 75.9M in quarter (+47.4% YoY), total payment volume through Mercado Pago topped $17.5B (+56.3% in USD), gross merchandise volume $7B (+39.2% in USD) Ping Identity ($PING) 2Q adj EPS $0.11 vs est. $0.04 on revs $78.9Mm vs est. $66.1Mm; guides 3Q revs $65-70Mm vs est. $65.1Mm, sees 3Q total ARR $286-288Mm; guides FY revs $278-285Mm vs est. $269.3Mm, sees FY total ARR $304-306Mm Qorvo ($QRVO) Q1 EPS $2.83 vs. est. $2.45; Q1 revs $1.11B vs. est. $1.08B; sees Q2 EPS $3.24 at midpoint vs. est. $3.02; sees Q2 revenue $1.24B-$1.26B vs. est. $1.21B Trimble Inc. ($TRMB) Q2 adj EPS $0.72 vs. est. $0.59; Q2 revs $945.3M vs. est. $867.8M; sees FY21 adj EPS $2.45-$2.65 vs. est. $2.45; sees FY21 adjusted revenue $3.55B-$3.65B vs. est. $3.48B; Q2 annualized recurring revenue (ARR) was $1.35 billion, up 11% yoy Western Digital ($WDC) 4Q adj EPS $2.16 vs est. $1.51 on revs $4.9B vs est. $4.55B; guides 1Q revs $4.9-5.1B vs est. $4.9B, sees 1Q adj EPS $2.25-2.55 vs est. $2.05

but if does then I can convert my ea to mt5

how is your newest EA doing...

$EA Reports Q1 EPS 71c, consensus 62c; Sees Q2 EPS roughly 36c, consensus $1.07; Raises FY22 EPS view to $1.58 from $1.34

Wednesday, August 4, 2021 Futures Up/Down % Last Dow -25.00 0.07% 34,973 S&P 500 -1.25 0.04% 4,413 Nasdaq 11.50 0.08% 15,058 U.S. S&P futures are flat heading into the trading day, looking to build on record highs from Tuesday as positive earnings boost U.S and European stocks while worries over China’s gaming and technology crackdown ease, helping lift those markets. Risk sentiment improves across Asia as Chinese and Hong Kong stocks push higher on tech recovery and solid Caixin PMI data. In Asian markets, The Nikkei Index fell -57 points to 27,854, the Shanghai Index rose 29 points to 3,477 and the Hang Seng Index jumped 231 points to settle at 26,426. In Europe, the German DAX is climbing around 125 points to 15,680, while the FTSE 100 is up 0.4% to 7,135. Chinese Jul Caixin Services PMI beat: 54.9 vs 50.6 consensus. Some also see the spread of the Covid-19 delta variant as delaying rather than stopping the economic recovery. The New York Times reported overnight that the FDA plans to give full approval to Pfizer (PFE) and BioNTech (BNTX) coronavirus vaccine by the start of the next month. Earnings season has been strong with about 87% of S&P 500 companies reporting earnings and revenue beats, according to FactSet. Just under 70% of the S&P 500 now has reported earnings. The S&P 500 closed at record highs with gains in Apple and healthcare stocks, as concerns over a surge in the Delta variant of the coronavirus was put to the back-burner, overshadowed by continued upbeat corporate earnings. Ten of the 11 S&P indexes traded higher, with energy stocks rebounding after getting hit by a dip in oil prices. Market Closing Prices Yesterday The S&P 500 Index gained 35.99 points, or 0.82%, to 4,423.15 The Dow Jones Industrial Average rose 278.24 points, or 0.80%, to 35,116.40 The Nasdaq Composite climbed 80.23 points, or 0.55%, to 14,761.29 The Russell 2000 Index advanced 8.09 points, or 0.36% to 2,223.58 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 8:15 AM ET ADP Employment Change for July…est. 695K 9:45 AM ET Markit Composite PMI, July-F 9:45 AM ET Markit Services PMI, July-F 10:00 AM ET ISM Non-Manufacturing Services PMI for July…est. 60.5 10:30 AM ET Weekly DOE Inventory Data Earnings Calendar: Earnings Before the Open: ABC, AEIS, ALE, APO, ASTE, BCOR, BDC, BGCP, BWA, CDW, CLVS, CLH, CLW, CMLS, CRL, CSII, DNOW, DOC, EDIT, EMR, ETR, EXC, FLOW, FUN, GEL, GM, HDSN, HFC, HZNP, IONS, JLL, KHC, LL, MAC, MKL, MPC, MPLX, MTOR, NI, NYT, ODP, RCL, SBGI, SGRY, SITE, SMG, SPR, SUP, TGI, TUP, TXMD, UTHR, VCEL, VMC, WLL Earnings After the Close: ACAD, ACLS, ADPT, ADTN, AGL, ALB, ALL, AMED, ANGI, ANSS, APA, ATO, AXGN, BBSI, BE, BFAM, BKNG, BOOT, CCMP, CDAY, CENX, CHNG, CMP, CPS, DGII, DOX, DVAX, DXC, EA, EGHT, ELF, EMKR, EOG, ETSY, EVH, FLT, FOXA, FSLY, FTDR, GDDY, GNK, HI, HUBS, IAC, INGN, IVR, JACK, LESL, LNC, LPI, LUMN, MAXR, MBI, MCK, MED, MET, MGM, MOD, MRO, MTG, NUS,NVRO, ONEM, PARR, PDCE, $PING, PLYA, QRVO, QTWO, RCII, REGI, RGR, RMAX, RNWK, EOKU, RPD, $RVLV, RYN, SBRA, SMSI, SUM, T$NDM, TPC, TTGT, TVTY, TWNK, TWO, TXG, $UBER, UHAL, VVV, VZIO, WDC, WU, YELL Other Key Events: Jefferies Industrials Conference (virtual), 8/3-8/4 Piper Wealth Management Forum (virtual), 8/3-8/6 Macro Up/Down Last Nymex -0.34 70.22 Brent -0.18 72.23 Gold 3.30 1,813.75 EUR/USD -0.0008 1.1856 JPY/USD 0.13 109.17 10-Year Note +0.008 1.182% Sector News Breakdown Consumer Caesar’s Entertainment ($CZR) Q2 EPS $0.34 vs. est. loss (-$0.26); Q2 revs $2.5B vs. est. $2.27B; Q2 same-store Adjusted EBITDA was $1B versus (-$131M) for the comparable prior-year period; Company posted all-time records in quarterly Adjusted EBITDA and Adjusted EBITDA margin. Denny’s ($DENN) Q2 adj EPS $0.18 vs. est. $0.11; Q2 revs $106.2M vs. est. $98.1M; Q2 domestic system-wide same-store sales decreased 1.2% compared to the equivalent fiscal period in 2019, including a 1.5% decrease at domestic franchised restaurants and a 1.9% increase at company restaurants. Herbalife ($HLF) Q2 adj EPS $1.52 vs. est. $1.29; Q2 revs $1.55B vs. est. $1.57B; Q2 adjusted EBITDA of $262.1M; raises FY21 EPS view to $4.70-$5.10 from $4.65-$5.05 (est. $4.93); sees FY net sales growth to be in a range of 8.5% to 12.5%, lowering the midpoint by 150 basis points compared to prior full year 2021 guidance. Host Hotels ($HST) Q2 adj FFO $0.12 vs. est. $0.04; Q2 revs $649M vs. est. $606.58M; said RevPAR reached nearly $100 for the quarter, which dramatically outperformed consensus RevPAR, with average room rates only 8.4% below our 2019 second quarter rates; not providing year guidance Hyatt ($H) 2Q adj EPS ($1.15) vs est. ($0.85) on comparable system-wide REVPAR $72.47, qtrly total revs $663Mm vs est. $686.9Mm; guides FY net rooms growth more than +6%, sees FY adj SG&A about $240Mm, sees FY CAPEX about $110Mm Energy Devon Energy ($DVN) Q2 adj EPS $0.60 vs est. $0.52 on revs $2.42B vs est. $2.35B, operating cash flow $1.1B, production for the quarter averaged 291k barrels/day; will pay total dividend of 49c/shr (11c fixed + 38c variable), a 44% increase from Q1; sees 3q production 566-594 mboe/d vs est. 564.80 mboe/d Occidental Petroleum ($OXY) Q2 adj EPS 32c vs est. 1c on revs $5.96B vs est. $5.92B, FCF $2B, cash flow from continuing operations $3.3B; said oil and gas results improved from Q1 due to higher commodity prices and sales volumes; executed debt tender offer and repaid over $3B of long-term debt in July ONEOK ($OKE) Q2 EPS $0.77 vs. est. $0.75; Q2 revs $3.39B vs. est. $3.03B; sees 2021 net income, adj earnings before interest, taxes, depreciation, amortization to be above midpoints of ranges provided on April 27, 2021 SunPower ($SPWR) Q2 adj EPS $0.06 vs. est. $0.04; Q2 revs $308.9M vs. est. $327.31M; guides Q3 revs $325M-$375M vs. est. $400.83M; sees Q3 GAAP net loss of $10 to $0 million and MW recognized of 125 MW to 150 MW; Q2 added 13,000 residential customers – residential bookings up 16 percent sequentially, 67 percent year-over-year (YoY) The American Petroleum Institute ($API) showed a draw of 879K barrels of oil for the latest week; gasoline inventories show a draw of 5.75M barrels, distillate inventories show a draw of 717K barrels and Cushing inventories show a build of 659K barrels W&T Offshore ($WTI) Q2 EPS $0.02 vs. est. $0.07; Q2 revs $132.8M vs. est. $122.38M; Q2 Production was 40,888 Boe/d or 3.7 MMBoe, an increase of 3% compared to 39,657 Boe/d in Q1 and down 3% versus 42,037 Boe/d in Q2 of 2020 Financials Assurant Inc. ($AIZ) Q2 operating EPS $2.99 vs. est. $2.45; Q2 revs $2.54B vs. est. $2.39B; continue to expect to grow eps, ex. catastrophes, by 10 to 14 percent for 2021 Fair Isaac ($FICO) Q3 non-GAAP EPS $3.38 vs. est. $2.76; Q3 revs $338M vs. est. $328.3M; Applications revenues, which include the company’s decision management applications and associated professional services, were $133.2 million in the third quarter, compared to $141.5 million in the prior year period, a decrease of 6% Genworth Financial ($GNW) Q2 adj EPS $0.38 vs. est. $0.22; Q2 revs $2.04B vs. est. $1.9B; planned IPO of Enact remains a key strategic objective for Genworth and is subject to market and other conditions, however because the company is in registration and subject to applicable publicity restrictions, is unable to comment further or provide any additional detail at this time. Green Dot ($GDOT) Q2 adj EPS $0.68 vs est. $0.43 on revs $369.4M vs est. $313.2M; sees FY21 adj EPS $2.13-$2.27 vs prev. $2.06-$2.15, revs $1.33B-$1.35B vs est. $1.28B Prudential ($PRU) Q2 adj EPS $3.79 vs. est. $3.02; qtrly book value per common share of $160.31 versus $165.53 per share for year-ago; qtrly adjusted book value per common share of $104.39 versus $92.07 per share for year-ago; qtr end assets under management of $1.730 trillion versus $1.605 trillion for year-ago; now expect to return a total of $11.0B to holders from $10.5B prior Tanger Outlets ($SKT) 2Q core FFO/shr $0.43 vs est. $0.28, portfolio occupancy was 93% on June 30 vs 91.7% on March 31, avg tenant sales productivity was $424/sq ft for 12 months ended June 30 +7.3% yr/yr; guides FY FFO/shr $1.52-1.59 vs est. $1.46 Unum Group (UNM) Q2 adj EPS $1.39 vs. est. $1.11; Q2 revs $2.99B vs. est. $2.96B; Full-year 2021 outlook increased; after-tax adjusted operating income per share now expected to decline 1%-3% relative to full-year 2020, compared to an expected decline of 5%-6% prior Verisk Analytics ($VRSK) Q2 adj EPS $1.17 vs. est. $1.33; Q2 revs $747.5M vs. est. $737.3M; Net cash provided by operating activities was $233.2 million, down 6.5% for the second quarter of 2021. Free cash flow, a non-GAAP measure, was $170.7 million, down 11.5% Healthcare Change Healthcare ($CHNG) shares fell over 7% on a report that the U.S. Dept. of Justice is considering a lawsuit to block the company’s $8B sale to UnitedHealth ($UNH) https://bit.ly/3yA4Etu Option Care Health ($OPCH) 18M share Spot Secondary priced at $20.25 Amgen Inc. ($AMGN) Q2 adj EPS $4.38 vs. est. $4.06; Q2 revs $6.5B vs. est. $6.43B; backs FY21 adj EPS view $16.00-$17.00 vs. est. $16.34; backs FY21 revenue view $25.8B-$26.6B vs. est. $26.04B Amid surge in new COVID-19 infections across U.S., the FDA plans to give full approval to Pfizer (PFE) – BioNTech (BNTX) coronavirus vaccine by the start of the next month, The New York Times reports The FDA classified the recent recall of some of Philips’ (PHG) ventilators as Class 1, or the most serious type of recall, saying the use of these devices may cause serious injuries or death – Reuters CVS Health ($CVS) Q2 adj EPS $2.42 vs. est. $2.06; Q2 revs $72.62B vs. est. $70.11B; raises FY21 adjusted EPS view to $7.70-$7.80 from $7.56-$7.68 (est. $7.66); sees FY21 cash flow from operations $12.5B-$13B DaVita Inc. (DVA) 2Q EPS $2.64 vs est. $2.17; says total US dialysis treatments for 2Q were 7,413497 (avg 95,045/day); guides FY adj EPS $8.80-9.40 vs est. $8.63, sees FY adj op income $1.8-1.875B vs est. $1.816B Inspire Medical ($INSP) 2Q EPS ($0.48) vs est. ($0.64) on revs $53Mm vs est. $43.9Mm; guides FY revs $210-213Mm vs est. $195.9Mm, sees FY gr mgn 85-86%, sees opening 48-52 new US medical centers per qtr for 2H Jazz Pharma ($JAZZ) Q2 adj EPS $3.90 vs. est. $3.42; Q2 revs $751.8M vs. est. $735.62M; reaffirms FY21 non-GAAP EPS view $13.40-$14.70 (est. $14.45) and also back FY21 revenue view $3.020B-$3.180B vs. est. $3.11B; as of June 30, cash, cash equivalents were $891.4 mln, and outstanding principal balance of co’s long-term debt was $7.1 bln

ea is not for me, i tried to program it (signals), but the result was tragic 😋

after making the EA, and getting the key